Current status of the application of botulinum toxin as a treatment option for trigeminal neuralgia
Cranio
.
2021 Jan;39(1):1-3.
doi: 10.1080/08869634.2020.1849976.
Authors
Valerie Chávez-Pérez
1
,
Natalia Felipe-Spada
1
,
Javier Roldán-Cubero
2
,
Patricia Freire-Nieto
1
,
Jordi Tomàs-Aliberas
3
Affiliations
1
Department of TMJ, Universitat Internacional de Catalunya , Barcelona, Spain.
2
Department of Restorative Dentistry, Universitat Internacional de Catalunya , Barcelona, Spain.
3
Department of TMJ, Universitat Internacional de Catalunya , Barcelona, Spain,
[email protected]
.
PMID:
33357140
DOI:
10.1080/08869634.2020.1849976
No abstract available
Publication types
Editorial
MeSH terms
Botulinum Toxins*
Humans
Pain Measurement
Trigeminal Neuralgia* / drug therapy
Substances
Botulinum Toxins